Switzerland continues to play a key role in the sustainable development of biotechnology. The EPFL campus strengthens an academic output which creates a strong bio-economy moving forward. Those considerations led A3P to organize the coming congress in Lausanne (SwissTech convention Center – EPFL) in the heart of the health valley. The choices of conferences are becoming more and more difficult. But the agenda elaborated by the A3P editorial committee represents original works of key interest at the cutting edge of development and manufacturing. The biopharmaceutical industry needs to be able to reduce the cost of some biotech drugs products 10 fold. This major industry challenge has been the driver for the proposed agenda.